Starting in 2018, there will be a charge of $200 from ACPE for filing for CE after the 60-day submission deadline. NCPA has established "free pass" filing periods for March, August, and December of 2018 where your overdue activities can still be filed at no charge. Please contact Sue Hagler at firstname.lastname@example.org with any questions and activities you need submitted. Have the following information ready: e-Profile ID, DOB (MMDD), and ACPE UAN for each activity.Read more
Smith Drug Company and Burlington Drug Company recently joined with more than 115 other health care groups to endorse bipartisan legislation that would prohibit pharmacy benefit managers from adding retroactive charges on Medicare Part D prescription drugs.
The effect of those fees is to raise costs for seniors, taxpayers and pharmacies.
The National Community Pharmacists Association (NCPA) announced today a nationwide campaign to let Congress know the importance of giving Medicare beneficiaries better access to the pharmacy of their choice and letting community pharmacies in medically underserved areas have the opportunity to participate as "preferred" pharmacies in Medicare drug plans.
"The Medicare pharmacy choice proposal, H.R. 4577, is popular with voters, supported by key consumer advocates and has strong, bipartisan backing from dozens of cosponsors," said NCPA CEO B. Douglas Hoey, RPh, MBA. "But pharmacy choice supporters need to educate more members of Congress and ask them to cosponsor H.R. 4577. They should ask their senators to introduce 'any willing pharmacy' legislation in the Senate. The August congressional recess is the ideal time for pharmacists and other supporters to engage their elected representatives, and these tools and resources that NCPA has provided make it easy."